Pharmaceuticals in Spain
Description
Pharmaceuticals in Spain
Summary
Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
- The Spanish pharmaceuticals market recorded revenues of $30.6 billion in 2024, representing a compound annual growth rate (CAGR) of 4.0% between 2019 and 2024.
- The central nervous system drugs segment accounted for the market's largest proportion in 2024, with total revenues of $4.3 billion, equivalent to 14.0% of the market's overall value.
- The Spanish pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 5.8%.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Spain
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Spain
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Spain pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Spain pharmaceuticals market by value in 2024?
- What will be the size of the Spain pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the Spain pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in Spain's pharmaceuticals market?
Table of Contents
36 Pages
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths of leading players?
- 7.3. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. Almirall SAS
- 8.2. Grifols SA
- 8.3. Laboratorios Farmaceuticos Rovi SA
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Spain pharmaceuticals market value: $ million, 2019-24
- Table 2: Spain pharmaceuticals market category segmentation: % share, by value, 2019-24
- Table 3: Spain pharmaceuticals market category segmentation: $ million, 2019-24
- Table 4: Spain pharmaceuticals market geography segmentation: $ million, 2024
- Table 5: Spain pharmaceuticals market value forecast: $ million, 2024-29
- Table 6: Almirall SAS: Key Facts
- Table 7: Grifols SA: Key Facts
- Table 8: Grifols SA: Annual Financial Ratios
- Table 9: Grifols SA: Key Employees
- Table 10: Laboratorios Farmaceuticos Rovi SA: Key Facts
- Table 11: Laboratorios Farmaceuticos Rovi SA: Annual Financial Ratios
- Table 12: Laboratorios Farmaceuticos Rovi SA: Key Employees
- Table 13: Spain Size of Population (Million), 2020-24
- Table 14: Spain Real GDP (Constant 2010 Prices, $ Billion), 2020-24
- Table 15: Spain GDP (Current Prices, $ Billion), 2020-24
- Table 16: Spain Inflation, 2020-24
- Table 17: Spain Consumer Price Index (Absolute), 2020-24
- Table 18: Spain Exchange Rate, 2019-24
- List of Figures
- Figure 1: Spain pharmaceuticals market value: $ million, 2019-24
- Figure 2: Spain pharmaceuticals market category segmentation: $ million, 2019-24
- Figure 3: Spain pharmaceuticals market geography segmentation: % share, by value, 2024
- Figure 4: Spain pharmaceuticals market value forecast: $ million, 2024-29
- Figure 5: Forces driving competition in the pharmaceuticals market in Spain, 2024
- Figure 6: Drivers of buyer power in the pharmaceuticals market in Spain, 2024
- Figure 7: Drivers of supplier power in the pharmaceuticals market in Spain, 2024
- Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Spain, 2024
- Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Spain, 2024
- Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Spain, 2024
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
